Molecular pathogenesis and the role of tumor markers in cholangiocarcinoma.
- Author:
Jin LEE
1
;
Dong Hee KOH
Author Information
1. Department of Internal Medicine, Hallym University College of Medicine, Seoul, Korea.
- Publication Type:Review
- Keywords:
Cholangiocarcinoma;
Molecular pathogenesis;
Tumor marker
- MeSH:
Bile;
Bile Ducts;
Cholangiocarcinoma;
Epithelial Cells;
Incidence;
Prognosis;
Biomarkers, Tumor
- From:Korean Journal of Medicine
2010;79(6):597-604
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Cholangiocarcinoma is a devastating cancer originating from the epithelial cell lining of the bile duct, whose prognosis is poor due to suboptimal response to therapy despite the fact that the incidence is increasing. Hence surgery still remains the only curative treatment option for cholangiocarcinoma. Recent investigations into the underlying biochemical and molecular mechanisms in biliary carcinogenesis and tumor growth, may illuminate new therapeutic modalities and suggest some new serum and bile markers that could be useful for the diagnosis of cholangiocarcinoma. In this review, we discuss the molecular mechanisms of pathogenesis in cholangiocarcinoma and the role of new tumor makers for the diagnosis of cholangiocarcinoma.
